BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 19237719)

  • 21. Incidence and Progression of Chronic Kidney Disease After Hepatitis C Seroconversion: Results from ERCHIVES.
    Rogal SS; Yan P; Rimland D; Lo Re V; Al-Rowais H; Fried L; Butt AA;
    Dig Dis Sci; 2016 Mar; 61(3):930-6. PubMed ID: 26526451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autoimmune cytopenias associated with inflammatory bowel diseases: Insights from a multicenter retrospective cohort.
    Uzzan M; Galicier L; Gornet JM; Oksenhendler E; Fieschi C; Allez M; Bouhnik Y; Kirchgesner J; Boutboul D; Treton X; Gérard L; Mahévas M; Cosnes J; Amiot A
    Dig Liver Dis; 2017 Apr; 49(4):397-404. PubMed ID: 28063954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fatal fulminant hemolysis-associated pulmonary embolism in mixed-type autoimmune hemolytic anemia: A case report.
    Imataki O; Iseki K; Uchida S; Uemura M; Kadowaki N
    Medicine (Baltimore); 2020 Feb; 99(6):e18984. PubMed ID: 32028408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human Immunodeficiency Virus Infection Increases the Risk of Incident Autoimmune Hemolytic Anemia: A Population-Based Cohort Study in Taiwan.
    Yen YF; Lan YC; Huang CT; Jen IA; Chen M; Lee CY; Chuang PH; Lee Y; Morisky DE; Chen YA
    J Infect Dis; 2017 Nov; 216(8):1000-1007. PubMed ID: 29149339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis C virus infection among patients with chronic immune thrombocytopenic purpura in northern India.
    Varma S; Kumar S; Garg A; Malhotra P; Das A; Sharma A; Chawla YK; Dhiman RK
    J Clin Exp Hepatol; 2011 Sep; 1(2):68-72. PubMed ID: 25755317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemiology of immune thrombocytopenic purpura in the General Practice Research Database.
    Schoonen WM; Kucera G; Coalson J; Li L; Rutstein M; Mowat F; Fryzek J; Kaye JA
    Br J Haematol; 2009 Apr; 145(2):235-44. PubMed ID: 19245432
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Red cell aplasia and autoimmune hemolytic anemia following immunosuppression with alemtuzumab, mycophenolate, and daclizumab in pancreas transplant recipients.
    Elimelakh M; Dayton V; Park KS; Gruessner AC; Sutherland D; Howe RB; Reding MT; Eastlund T; van Burik JA; Singleton TP; Gruessner RW; Key NS
    Haematologica; 2007 Aug; 92(8):1029-36. PubMed ID: 17640860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biologic false-positive serologic tests for syphilis and other serologic abnormalities in autoimmune hemolytic anemia and thrombocytopenic purpura.
    Conley CL; Savarese DM
    Medicine (Baltimore); 1989 Mar; 68(2):67-84. PubMed ID: 2646509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune thrombocytopenic purpura might be an early hematologic manifestation of undiagnosed human immunodeficiency virus infection.
    Lai SW; Lin HF; Lin CL; Liao KF
    Intern Emerg Med; 2017 Mar; 12(2):157-162. PubMed ID: 27562379
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autoimmune hepatitis-primary biliary cirrhosis overlap syndrome concomitant with immune hemolytic anemia and immune thrombocytopenic purpura (Evans syndrome).
    Korkmaz H; Bugdaci MS; Temel T; Dagli M; Karabagli P
    Clin Res Hepatol Gastroenterol; 2013 Apr; 37(2):e45-50. PubMed ID: 23273499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: A population-based study of U.S. veterans.
    El-Serag HB; Engels EA; Landgren O; Chiao E; Henderson L; Amaratunge HC; Giordano TP
    Hepatology; 2009 Jan; 49(1):116-23. PubMed ID: 19085911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune cytopenias as a continuum in inborn errors of immunity: An in-depth clinical and immunological exploration.
    Zama D; Conti F; Moratti M; Cantarini ME; Facchini E; Rivalta B; Rondelli R; Prete A; Ferrari S; Seri M; Pession A
    Immun Inflamm Dis; 2021 Jun; 9(2):583-594. PubMed ID: 33838017
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Performance of the Pooled Cohort atherosclerotic cardiovascular disease risk score in hepatitis C virus-infected persons.
    Chew KW; Bhattacharya D; Horwich TB; Yan P; McGinnis KA; Tseng C; Freiberg MS; Currier JS; Butt AA
    J Viral Hepat; 2017 Oct; 24(10):814-822. PubMed ID: 28273386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of hepatitis C virus treatment on the risk of non-hepatic cancers among hepatitis C virus-infected patients in the US.
    Wang W; Lo Re V; Guo Y; Xiao H; Brown J; Park H
    Aliment Pharmacol Ther; 2020 Nov; 52(10):1592-1602. PubMed ID: 32931606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors of hospitalisation for thrombosis in adults with primary immune thrombocytopenia, including disease-specific treatments: a French nationwide cohort study.
    Lafaurie M; Maquet J; Baricault B; Ekstrand C; Christiansen CF; Linder M; Bahmanyar S; Nørgaard M; Sailler L; Lapeyre-Mestre M; Sommet A; Moulis G
    Br J Haematol; 2021 Nov; 195(3):456-465. PubMed ID: 34386974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Mixed-type autoimmune hemolytic anemia after splenectomy for idiopathic thrombocytopenic purpura].
    Toyota S; Nakamura N; Dan K
    Rinsho Ketsueki; 2001 Jan; 42(1):51-3. PubMed ID: 11235135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hodgkin lymphoma presenting with various immunologic abnormalities, including autoimmune hepatitis, Hashimoto's thyroiditis, autoimmune hemolytic anemia, and immune thrombocytopenia.
    Saitoh T; Matsushima T; Saito Y; Yamane A; Yokohoma A; Irisawa H; Handa H; Tsukamoto N; Karasawa M; Kojima M; Nojima Y; Murakami H
    Clin Lymphoma Myeloma; 2008 Feb; 8(1):62-4. PubMed ID: 18501091
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Small molecule phagocytosis inhibitors for immune cytopenias.
    Neschadim A; Kotra LP; Branch DR
    Autoimmun Rev; 2016 Aug; 15(8):843-7. PubMed ID: 27296447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis C viral load, genotype, and increased risk of developing end-stage renal disease: REVEAL-HCV study.
    Lai TS; Lee MH; Yang HI; You SL; Lu SN; Wang LY; Yuan Y; L'Italien G; Chien KL; Chen CJ;
    Hepatology; 2017 Sep; 66(3):784-793. PubMed ID: 28370058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autoimmune disease and chronic lymphocytic leukemia: autoimmune hemolytic anemia, pure red cell aplasia, and autoimmune thrombocytopenia.
    Diehl LF; Ketchum LH
    Semin Oncol; 1998 Feb; 25(1):80-97. PubMed ID: 9482530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.